Casgevy: UK approves gene-editing drug for sickle cell Medical regulators approve a gene therapy that aims to cure sickle cell disease and beta thalassemia.
|
Casgevy: UK approves gene-editing drug for sickle cell Medical regulators approve a gene therapy that aims to cure sickle cell disease and beta thalassemia.
|